Donafenib as Adjuvant Therapy Following Ablation for Recurrent HCC

NCT06609876 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
108
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Sun Yat-sen University

Collaborators